Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective. Obesity has been strongly linked to endometrial cancer (EC) risk. A number of potential EC risk bio-markers have been proposed, including heightened pro-inflammatory cytokines and adipokines. To evaluate if bariatric surgery can serve as a means for altering levels of such EC risk biomarkers, we investigated changes in these biomarkers after weight loss. Methods. Blood samples were collected pre-operatively and 6 months post-operatively in107 female bariatric surgery patients aged 18–72 years. Wilcoxon signed-rank tests were used to compare biomarker levels (measured using xMAP immunoassays) pre- and post-surgery. Normative comparisons were implemented to contrast 6-month post-surgery biomarker levels to levels in a sample of 74 age-matched non-obese women. Linear regression was used to evaluate the relationship between biomarker expression at baseline and 6 months post-surgery and the relationship between race and biomarker levels. Results. On average, participants lost 30.15 kg (SD: 12.26) after the bariatric intervention. Levels of C-peptide, insulin, CRP, leptin, IL-1Rα, and IL-6 significantly decreased, while levels of SHBG, IGFBP1, and adiponectin significantly increased with weight loss. Normative comparisons showed the levels of SHBG, C-peptide, insulin, IGFBP1, adiponectin, CRP, and TNFα after bariatric intervention approached the level of markers in comparison group. Multiple regression analyses revealed significant relationships between changes in BMI and changes in biomarker levels. The changes in IL-1Rα were significantly associated with race. Conclusions. Our findings demonstrate that normalization of EC risk biomarkers can be achieved with bariatric surgery. Improved understanding of biological mechanisms associated with weight loss may inform preventive strategies for EC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sjöström, L., Gummesson, A., Sjöström, C. D., Narbro, K., Peltonen, M., Wedel, H., Bengtsson, C., Bouchard, C., Carlsson, B., Dahlgren, S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70159-7 · Cited by 770
Cancello, R., & Clément, K. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01004.x · Cited by 418
USA endometrial cancer projections to 2030: should we be concerned?
Sheikh, M. A., Althouse, A. D., Freese, K. E., Soisson, S., Edwards, R. P., Welburn, S., Sukumvanich, P., Comerci, J., Kelley, J., LaPorte, R. E., et al. (2014) · Future Oncology · doi:10.2217/fon.14.192 · Cited by 236 · cited 1×
“A recent publication from our group estimates a 55% increase in the incidence of EC by 2030 [2].”
BackgroundSelf-citationCytokines, stress, and depressive illness
Anisman, H., & Merali, Z. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00009-0 · Cited by 225
Anveden, Å., Taube, M., Peltonen, M., Jacobson, P., Andersson-Assarsson, J. C., Sjöholm, K., Svensson, P.-A., & Carlsson, L. M. S. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.02.036 · Cited by 134
Burke, L. E., Styn, M. A., Glanz, K., Ewing, L. J., Elci, O. U., Conroy, M. B., Sereika, S. M., Acharya, S. D., Music, E., Keating, A. L., et al. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.07.003 · Cited by 121
Tumor necrosis factor (TNF)‐α, soluble TNF receptors and endometrial cancer risk: The EPIC study
Dossus, L., Becker, S., Rinaldi, S., Lukanova, A., Tjønneland, A., Olsen, A., Overvad, K., Chabbert‐Buffet, N., Boutron‐Ruault, M., Clavel‐Chapelon, F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25840 · Cited by 75
Cited by
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Mechanick, J. I., Apovian, C., Brethauer, S., Timothy Garvey, W., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 389
Thomas, M. K., Nikooienejad, A., Bray, R., Cui, X., Wilson, J., Duffin, K., Milicevic, Z., Haupt, A., & Robins, D. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa863 · Cited by 345
“IGFBP-1 levels increase with weight loss after bariatric surgery or calorie restriction (35, 36).”
BackgroundThe Role of Metabolic Syndrome in Endometrial Cancer: A Review
Yang, X., & Wang, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00744 · Cited by 159
“C-peptide, insulin, C-reactive protein, leptin, IL-1Ralpha, and IL-6 decreased significantly, while SHBG, IGFBP1, and adiponectin increased significantly in weight-loss interventions in endometrial cancer (126).”
Background
Metadata
- Authors
- Linkov, F., Goughnour, S. L., Ma, T., Xu, Z., Edwards, R. P., Lokshin, A. E., Ramanathan, R. C., Hamad, G. G., McCloskey, C., & Bovbjerg, D. H.
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 147
- Issue
- 1
- Pages
- 133-138
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W2742363004
- Cited by
- 41
- References
- 7
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss. https://app.cochat.ai/papers/10.1016/j.ygyno.2017.07.144
- The paper
- Linkov, F., Goughnour, S. L., Ma, T., Xu, Z., Edwards, R. P., Lokshin, A. E., Ramanathan, R. C., Hamad, G. G., McCloskey, C., & Bovbjerg, D. H. (2017). Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2017.07.144
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.